Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism T3SS inhibitors(Type III secretion system protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pseudomonas aeruginosa infection | Phase 2 | GB | 22 Aug 2023 | |
Pseudomonas Infections | Discovery | JP | 28 Mar 2018 |